Development of an acellular bioengineered matrix with a dominant vascular pedicle

Keyphrases

• Bioengineering 100%
• Acellular 100%
• Vascular Pedicle 100%
• Lambda DNA 100%
• Patency 66%
• Fasciocutaneous Flap 66%
• Decellularized 66%
• Decellularization 66%
• Spectrophotometry 66%
• Histology 33%
• DNase 33%
• Extracellular Matrix 33%
• Young Males 33%
• Pedicle 33%
• Hematoxylin 33%
• Sprague-Dawley Rats 33%
• Vessel Wall 33%
• Histologic Examination 33%
• Perfusion 33%
• Sequential Treatment 33%
• Extracellular Matrix Protein 1 (ECM1) 33%
• Flap 33%
• Sodium Azide 33%
• Cannulated 33%
• Continuous Perfusion 33%
• Tissue Engineering 33%
• Phosphate-buffered Saline 33%
• Cellular Components 33%
• Cellular Constituents 33%
• Gross Examination 33%
• Engineered Tissue 33%
• Abdominal Wall 33%
• Customizable 33%
• Matrix Architecture 33%
• Vascular Network 33%
• Tissue Matrix 33%
• Superficial Inferior Epigastric Artery 33%
• Sodium Deoxycholate 33%
• Engineering Platform 33%
• Orcein 33%
• Fasciocutaneous 33%
• Non-processed 33%
• Perfusion Pump 33%
• Macrochannels 33%

Medicine and Dentistry

• Vascular Pedicle 100%
• Fasciocutaneous Flap 100%
• Spectrophotometry 100%
• Decellularization 100%
• Extracellular Matrix 50%
• Inferior Epigastric Artery 50%
• Pedicle 50%
• Haematoxylin 50%
• Engineered Tissue 50%
• Sodium Azide 50%
• Ex Vivo 50%
• Phosphate Buffered Saline 50%
• Tissue Regeneration 50%
• Abdominal Wall 50%
• Scleroprotein 50%
• Vascular Network 50%
• Orcein 50%
• Deoxycholate Sodium 50%